Brown-Forman Corp (BF5B.BE)
- Investing.com
4 big analyst picks: CVS picks up upgrade on 'attractive risk/reward,' per Wolfe
Here is your Pro Recap of the biggest analyst picks you may have missed since Friday: upgrades at CVS Health, Brown Forman, Geron, and a buy initiation for Block. Wolfe Research upped CVS Health (NYSE: NYSE:CVS) to Outperform from Peerperform with a price target of $80.00, prompting the shares to shoot higher after word of the upgrade hit the wires intraday Monday.
- Zacks
Brown-Forman (BF.B) Q1 Earnings & Sales Miss on Soft Trends
Brown-Forman's (BF.B) Q1 results reflect the impacts of difficult shipment comparisons from last year's inventory rebuild to overcome the glass supply challenges. Higher costs hurt the bottom line.
- Zacks
Brown-Forman B (BF.B) Q1 Earnings and Revenues Lag Estimates
Brown-Forman B (BF.B) delivered earnings and revenue surprises of -7.69% and 1.42%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?
